Bipolar disorder

Bipolar, or manic-depressive disorder, is a mood disorder that causes radical emotional changes and mood swings, from manic highs to depressive lows. The majority of bipolar individuals experience alternating episodes of mania and depression.

Eli Lilly denied NYT report of schizophrenia drug Zyprexa

Eli Lilly and Company (NYSE: LLY) called the assertions in a New York Times online article ‘flat out wrong.’ A report in The New York Times that said a senior executive had encouraged the promotion of its schizophrenia drug Zyprexa for a use not approved by federal regulators. – Eli Lilly and Company (NYSE: LLY) called the assertions in a New York Times online article ‘flat out wrong.’ A report in The New York Times that said a senior executive had encouraged the promotion of its schizophrenia drug Zyprexa for a use not approved by federal regulators.

Suicidal thoughts and behaviours from epilepsy drugs, alerts Medsafe

Medsafe, New Zealand’s Ministry of Health’s medicines regulatory arm, is alerting health care professionals in New Zealand about a small increased risk of suicidal thoughts and behaviours in patients taking anti-epileptic medicines. – Medsafe, New Zealand’s Ministry of Health’s medicines regulatory arm, is alerting health care professionals in New Zealand about a small increased risk of suicidal thoughts and behaviours in patients taking anti-epileptic medicines.

Epilepsy drugs may raise suicide risk, warns FDA

The U.S. Food and Drug Administration today issued new information to health care professionals to alert them about an increased risk of suicidal thoughts and behaviors (suicidality) in patients who take drugs called antiepileptics to treat epilepsy, bipolar disorder, migraine headaches, and other conditions. – An increased risk of suicidal thoughts and behaviors (suicidality) in patients who take drugs called antiepileptics to treat epilepsy, bipolar disorder, migraine headaches, and other conditions, reported by U.S. Food and Drug Administration (FDA).

Pfizer updated CHANTIX label to quit smoking with more warnings

Pfizer’s CHANTIX label in the U.S. to include a warning for neuropsychiatric symptoms, including changes in behavior, agitation, depressed mood, suicidal ideation and suicidal behavior. – Cigarette smoking is associated with significant morbidity and mortality. Smoking is the leading preventable cause of disease and premature death in the United States, with more than 438,000 U.S. deaths annually attributable to smoking. Patients who smoke cigarettes should be counseled to quit. CHANTIX was approved in May of 2006 in the U.S. as an aid to smoking cessation.

Bright light therapy eases bipolar depression

Bright light therapy can ease bipolar depression in some patients, according to a study published in the journal Bipolar Disorders. – Bright light therapy can ease bipolar depression in some patients, according to a study published in the journal Bipolar Disorders. Researchers from the University of Pittsburgh School of Medicine’s Western Psychiatric Institute and Clinic studied nine women with bipolar disorder to examine the effects of light therapy in the morning or at midday on mood symptoms.

Health Newstrack